Gattefosse Formulation Seminar 2019
Early considerations in lipid-based strategy for poorly bioavailable compounds.
The issue of low bioavailability continues to hinder robust testing of drug discovery and development. Of the many available strategies, Self Emulsifying Drug Delivery Systems (SEDDS) have generated significant interest due to its ability to overcome drugs ' poor bioavailability issues with high bio-compatibility, regulatory acceptance, and simple manufacturing process .
This seminar will highlight some considerations that warrant a lipid based formulation as a strategy of choice, and the general outline of the development process applicable early in the drug discovery stage and late stage drug formulation.
Join this Seminar to understand :
1. The overarching strategy of bioavailability enhancement with self emulsifying drug delivery system
2. How Gattefosse can help simplify your drug development process
Suitable for:
Liquid, semisolid formulation in hard/softgel capsules for:
- New Chemical Entity drugs
- Life-cycle management products "Supergeneric " /"generic plus " & Over-the Counter products
If you would like to register for this seminar, please email Yousuf Mohammed [email protected] Registrations will close on the 25 August
